The Trudeau Institute was founded by Dr. Edward Livingston Trudeau in 1884 with the mission of finding a treatment and cure for Tuberculosis. He adopted the “outdoor air” treatment in the mountain region of New York, Saranac Lake. After the discovery of a drug treatment for tuberculosis was discovered in the 1950s, Trudeau Institute switched gears in research activity. Trudeau Institute is known for its research on the immune system, Lyme Disease and many auto-immune diseases. Trudeau Institute focuses on the study of the immune system to combat flu, cancer and other diseases with the hope of creating a vaccine.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacterial infections and the ...
Aug 28, 2012
0
0
New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, ...
Mar 12, 2012
3
0
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest ...
Dec 12, 2011
0
0
New research from the Trudeau Institute may help in the ongoing fight against tuberculosis. Dr. Andrea Cooper's lab has discovered a connection between the development of new lymphoid tissue within the lung and protection ...
Oct 18, 2011
0
0
Research underway at the Trudeau Institute could lead to new treatments for people sickened by Listeria and other sepsis-causing bacteria. Dr. Stephen Smiley's laboratory has published a study in the scientific journal Infection ...
Oct 17, 2011
0
0
New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection. The research is published in this month's issue of Vaccine. The journal ...
Aug 23, 2011
0
0
New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's ...
Jul 11, 2011
0
0
Researchers from the Smiley lab at the Trudeau Institute have now identified a single component of the plague causing bacterium that can be used as a vaccine. This single "subunit" could potentially be used to create a safer ...
Jun 27, 2011
0
0
